Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer.
- DOI
- 10.1007/s00262-018-2257-2
- Published
- 2019 Jan
- Container
- Cancer immunology, immunotherapy : CII
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00262-018-2257-2,
title = {Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer.},
author = {Zhang W and Lu X and Cui P and Piao C and Xiao M and Liu X and Wang Y and Wu X and Liu J and Yang L},
year = {2019},
journal = {Cancer immunology, immunotherapy : CII},
doi = {10.1007/s00262-018-2257-2},
url = {https://doi.org/10.1007/s00262-018-2257-2}
}RIS
TY - JOUR TI - Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer. AU - Zhang W AU - Lu X AU - Cui P AU - Piao C AU - Xiao M AU - Liu X AU - Wang Y AU - Wu X AU - Liu J AU - Yang L PY - 2019 JO - Cancer immunology, immunotherapy : CII DO - 10.1007/s00262-018-2257-2 UR - https://doi.org/10.1007/s00262-018-2257-2 ER -
APA
W, Z., X, L., P, C., C, P., M, X., X, L., Y, W., X, W., J, L., & L, Y. (2019). Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer.. Cancer immunology, immunotherapy : CII. https://doi.org/10.1007/s00262-018-2257-2
Source records
- pubmed · retrieved 2026-09-26T18:41:41.768Z
- europe-pmc · retrieved 2026-09-26T18:41:41.785Z